Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ovarian niche is a specialized and dynamic microenvironment within the ovary that provides the necessary structural, chemical, and cellular support for oocyte development and maturation (PMID: 30333160). It consists of various somatic cell types, such as granulosa and theca cells, embedded within an extracellular matrix and regulated by a network of endocrine, paracrine, and autocrine signals (Nature Reviews Endocrinology, 2018). This niche is fundamental to the process of folliculogenesis and the maintenance of the ovarian reserve, directly influencing female fertility and reproductive lifespan (PMID: 29447149). Within this environment, signaling pathways like BMP, Wnt, and Notch coordinate the transition of primordial follicles into growing follicles (PMID: 25639241). Pathological changes in the ovarian niche are associated with conditions like primary ovarian insufficiency (POI), polycystic ovary syndrome (PCOS), and the development of ovarian cancer (PMID: 31504623). In malignancy, the niche can be reprogrammed to support tumor growth, immune evasion, and metastasis (PMID: 33452140). Because the ovarian niche is a complex multi-cellular environment rather than a single molecule, it is not classified as a traditional therapeutic target (PMID: 30333160). However, individual components within the niche, such as hormone receptors and growth factor pathways, are frequently targeted by pharmacological interventions to treat infertility or cancer (Journal of Ovarian Research, 2021).
Not applicable as the ovarian niche is a multi-component microenvironment rather than a single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ovarian niche.